
jscreen’s Partnership with No Stomach For Cancer
No Stomach For Cancer works to prevent and treat stomach cancer through research, education, and advocacy. jscreen® is a national non-profit that shares the belief that everyone deserves access to testing that can protect themselves and their families from devastating genetic diseases.
Hereditary risk for stomach cancer can pass through a family for generations without an obvious pattern. Some inherited syndromes also increase the risk for breast cancer. Genetic testing gives you clear, direct answers you can act on.
Genetic Testing That Fits Your Needs
The health of your family depends on it
jscreen is a national genetic screening and education program offering access to comprehensive, at-home testing and genetic counseling.
Learn about hereditary cancer testing and find out what is right for you.
Hereditary Cancer Testing
Why
Results are actionable and can be used for cancer prevention, early detection, and treatment.
What
jscreen is a national non-profit that offers access to comprehensive hereditary cancer testing. This test includes CDH1, CTNNA1, BRCA1/2, Lynch syndrome, and more than 60 other cancer predisposition genes. A genetic counselor reviews every case at intake and helps patients understand their results and take actionable next steps.
Who
This cancer test is designed for anyone who wants to understand their inherited cancer risk, and it works for people of all ancestries. It is particularly valuable for people with a personal history of cancer; people with a family history of cancer, especially at a young age; people with multiple relatives affected by the same or related cancers; and people of Ashkenazi Jewish ancestry due to their higher rates of certain mutations. While the test is available starting at age 18, jscreen typically recommends waiting until around age 25, depending on family history and other risk factors.
Why Genetic Testing Matters
A hereditary cancer test looks for inherited variants that raise your risk of cancer, giving you and your doctor real information to act on together. A positive result opens up options like risk-reducing surgeries, targeted therapies, and family planning support. A negative result, which means no pathogenic variants were found in the genes tested, may mean risk is no higher than average population risk, which can bring peace of mind to many people.
Actionable results
Family Impact
Early Detection Advantage
Genetic Counseling Included
.webp)
Four Easy Steps to Access Genetic Screening from Home
Order Your Kit
Register online and receive a saliva collection kit shipped directly to your home within a few days.
Collect Your Sample
Provide a simple saliva sample at home, following the easy step-by-step instructions included in your kit.
Lab Analysis
Your sample is analyzed at a CLIA-accredited laboratory using advanced sequencing technology across the full gene panel.
Receive Results
Receive your results within 3 to 4 weeks. You can choose to schedule a complimentary consultation with a certified genetic counselor to review your findings.
Costs and Insurance Coverage
Insurance Billing
Self-Pay Option
If cost is a barrier to testing, financial assistance for lab fees may be available through No Stomach For Cancer.
Gene Table: Hereditary Stomach Cancer
The full gene list is available here. Results are reviewed by board certified genetic counselors. This is not a complete list of genes that should be tested when personal and/or family history features are present.
The gene associated with hereditary diffuse gastric cancer syndrome. Carriers face up to an 80% lifetime risk of stomach cancer, along with a higher risk of lobular breast cancer in female carriers.¹
A Lynch syndrome gene. Carriers face an 8–16% lifetime risk of stomach cancer, along with a significantly higher colorectal and uterine cancer risk.²
Diffuse gastric cancer (DGC) is the most common manifestation in germline CTNNA1 variant carriers, with one study estimating a 49–57% lifetime risk by age 80.3
A Lynch syndrome gene with a stomach cancer risk similar to MLH1, at 8–16%.²
A Lynch syndrome gene with a comparatively lower stomach cancer risk than MLH1 or MSH2, though still clinically relevant.²
The gene behind Peutz-Jeghers syndrome, which causes polyps throughout the digestive tract along with dark spots on the lips and mouth. Carriers face up to a 29% lifetime risk of stomach cancer.⁴
These genes are associated with juvenile polyposis syndrome, leading to multiple polyps in the stomach and intestines. Carriers face up to a 21% lifetime risk of stomach cancer.⁴
Certain changes in the promoter region of the APC gene cause gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS), marked by widespread stomach polyps and a stomach cancer risk between 7% and 30%.⁵
Stomach cancer may be preventable if you know your risk.
References
- Hereditary Diffuse Gastric Cancer (HDGC). Johns Hopkins Medicine website. 2024. Accessed August 10, 2026. https://www.hopkinsmedicine.org/health/conditions-and-diseases/hereditary-diffuse-gastric-cancer-hdgc
- Lynch Syndrome. GeneReviews. NCBI Bookshelf. 2021. Accessed August 10, 2026. https://www.ncbi.nlm.nih.gov/books/NBK1211/
- Benusiglio PR, et al. Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 variants. J Med Genet. Published online 2024. Accessed September 9, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13151538/
- Gastric Cancer. StatPearls. NCBI Bookshelf. 2024. Accessed August 10, 2026. https://www.ncbi.nlm.nih.gov/sites/books/NBK459142/
- Sarmiento Irizarry R, et al. Gastric Adenocarcinoma and Proximal Polyposis of the Stomach in a Hispanic Pediatric Patient With APC Gene Variant c.-191T>G. PMC. 2023. Accessed August 10, 2026. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191560/
